ascopubs.org

Phase I Study of C-TPF in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Prenatal Diagnosis, Preimplantation Genetic Diagnosis, and Cancer: Was Hamlet Wrong? Patients with previously untreated SCCHN were enrolled. FU cohorts were 700, 850, and 1,000 mg/m 2 /d for 4 days ...
ascopubs.org

Standard or split TPF induction chemotherapy followed by bioradiation: ICRAT randomized phase II study.

Randomised study of 2 low doses of sunitinib to modulate tumor microvasculature prior to chemotherapy in nasopharyngeal carcinoma (NPC). A phase 1 trial of vorinostat in combination with concurrent ...
The New England Journal of Medicine

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

A randomized phase 3 trial of the treatment of squamous-cell carcinoma of the head and neck compared induction chemotherapy with docetaxel plus cisplatin and fluorouracil (TPF) with cisplatin and ...
The New England Journal of Medicine

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

Phase 2 studies suggest that the standard regimen of cisplatin and fluorouracil (PF) plus docetaxel (TPF) improves outcomes in squamous-cell carcinoma of the head and neck. We compared TPF with PF as ...